Molecular Signaling Mechanisms Underlying Epileptogenesis

Science's STKE  10 Oct 2006:
Vol. 2006, Issue 356, pp. re12
DOI: 10.1126/stke.3562006re12

You are currently viewing the gloss.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


The epilepsies, disorders of recurrent seizures, affect about 1% of the population worldwide. Available therapy is symptomatic in that drugs inhibit seizures but are not disease-modifying; that is, no effective pharmacological prevention or cure has been identified. The term "epileptogenesis" refers to the process by which a normal brain becomes epileptic. Understanding the cellular mechanisms of epileptogenesis in molecular terms may help identify molecular targets for which small-molecule therapeutics can be developed to prevent epileptogenesis in individuals at high risk. A number of acquired and genetic causes of this disorder have been identified, and various in vivo and in vitro models of epileptogenesis have been established. The objective of this STKE Review, with 5 figures, 2 tables, and 199 references, is to review current insights into the molecular signaling mechanisms underlying epileptogenesis, focusing on limbic epileptogenesis in particular.

Cited By...